NEW YORK (GenomeWeb News) - Clinical Data's share price climbed 8 percent to $39 a share in late-morning trading today, reaching a new 52-week high.
 
Earlier this month, the company authorized a 3-for-2 stock split for shareholders of record as of Sept. 24. The new shares will be distributed Oct. 1.
 
Clinical Data’s shares are up more than 12 percent for the week beginning Sept. 24.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.